Barnell, Erica K.
Fisk, Bryan
Skidmore, Zachary L.
Cotto, Kelsy C.
Basu, Anamika
Anand, Aparna
Richters, Megan M.
Luo, Jingqin
Fronick, Catrina
Anurag, Meenakshi
Fulton, Robert
Ellis, Matthew J.
Griffith, Obi L.
Griffith, Malachi
Ademuyiwa, Foluso O.
Funding for this research was provided by:
National Cancer Institute (U01CA248235, U01CA248235, CA167540)
National Human Genome Research Institute (R00HG007940)
V Foundation for Cancer Research (V2018-007)
Article History
Received: 10 May 2022
Accepted: 21 September 2022
First Online: 22 October 2022
Competing interests
: These authors disclose the following: Erica Barnell is an owner, employee, and member of Geneoscopy Inc. Erica Barnell is an inventor of the intellectual property owned by Geneoscopy Inc. FOA receives research funding from Pfizer, Immunomedics, NeoImmuneTech, RNA Diagnostics, and Astellas, and fees from Teladoc Health, Pfizer, AstraZeneca, QED Therapeutics, Immunomedics, Cardinal Health, Athenex, and Biotheranostics. The remaining authors disclose no conflicts.